Cargando…

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms

Detalles Bibliográficos
Autor principal:	Turgeman, Gadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468753/ https://www.ncbi.nlm.nih.gov/pubmed/26109936 http://dx.doi.org/10.4103/1673-5374.156953

Ejemplares similares

Convergent functional genomics of stem cell-derived cells
por: Niculescu, A B
Publicado: (2013)

The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer’s disease?
por: Wang, Yanzhuang, et al.
Publicado: (2022)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Therapeutic potential of stem cells in orthopedics
por: Bahney, Chelsea Shields, et al.
Publicado: (2012)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type 1 Diabetes
por: Abdi, Reza, et al.
Publicado: (2008)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Converging multi-modality datasets to build efficient drug repositioning pipelines against Alzheimer’s disease and related dementias
por: Yin, Zheng, et al.
Publicado: (2022)

Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform
por: Baek, Gyuhyeon, et al.
Publicado: (2019)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease
por: Fernández-Vega, Iván, et al.
Publicado: (2020)

Rationale for Determining the Functional Potency of Mesenchymal Stem Cells in Preventing Regulated Cell Death for Therapeutic Use
por: Naji, Abderrahim, et al.
Publicado: (2016)

Melastatin-related transient receptor potential 2 channel in Aβ(42)-induced neuroinflammation: implications to Alzheimer’s disease mechanism and development of therapeutics
por: Wei, Linyu, et al.
Publicado: (2018)

hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics
por: TCW, Julia, et al.
Publicado: (2023)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Convergence of Cell Pharmacology and Drug Delivery
por: Aijaz, Ayesha, et al.
Publicado: (2019)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease
por: Phinney, Donald G.
Publicado: (2017)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Human stem cell-derived microglia will be an indispensable toolbox for Alzheimer’s disease research
por: Liu, Tongfei
Publicado: (2021)

Mesenchymal Stem Cells: Time to Change the Name!
por: Caplan, Arnold I.
Publicado: (2017)

Mesenchymal stem cells, implications for pain therapy
por: Trallori, Elena, et al.
Publicado: (2019)

Antibodies and Brain Disease: A Convergence of Immunology and Physiology
por: Diamond, Betty, et al.
Publicado: (2006)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease
por: Tang, Bor Luen
Publicado: (2020)

Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
por: González, Alexis, et al.
Publicado: (2016)

Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome
por: Marrazzo, Pasquale, et al.
Publicado: (2021)

Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells
por: Yang, Guoqiang, et al.
Publicado: (2023)

Mesenchymal stem cell therapy for severe COVID-19
por: Shi, Lei, et al.
Publicado: (2021)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Excitatory synapse impairment and mitochondrial dysfunction in Huntington’s disease: heat shock factor 1 (HSF1) converging mechanisms
por: Zarate, Nicole, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u360ulq5ip1o82g123nui7f5s9